James Rubenstein
James Rubenstein
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tafasitamab Plus Lenalidomide in Relapsed CNS Lymphoma | primary central nervous system lymphoma | Recruiting | Phase 1 / Phase 2 | 2026-07-14 | NCT05351593 | |
| Feasibility of Acquiring Hyperpolarized Imaging in Patients With Primary CNS Lymphoma | primary central nervous system lymphoma | Recruiting | Phase 1 | 2026-07-14 | NCT04656431 |